Get Ready for Questions About Enerzair for Asthma
December 2020
Enerzair Breezhaler will be the first "three-in-one" inhaler for adults with asthma.
Enerzair contains the inhaled corticosteroid (ICS) mometasone...the long-acting beta-agonist (LABA) indacaterol...and the long-acting muscarinic antagonist (LAMA) glycopyrronium.
Enerzair seems to improve lung function in asthma patients not controlled on a medium- or high-dose ICS/LABA.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive